Repository logo
 
Publication

The ligands of estrogen receptor alpha regulate Cytochrome P4502C9 (CYP2C9) expression

2011-07Journal article Restricted access
Simple item page
dc.contributor.authorMwinyi, Jessica
dc.contributor.authorCavaco, Isa
dc.contributor.authorYurdakok, Begum
dc.contributor.authorMkrtchian, Souren
dc.contributor.authorIngelman-Sundberg, Magnus
dc.date.accessioned2018-12-07T14:53:21Z
dc.date.available2018-12-07T14:53:21Z
dc.date.issued2011-07
dc.description.abstractCytochrome P4502C9 (CYP2C9) is an important drug-metabolizing enzyme responsible for the metabolism of approximately 16% of all clinically relevant drugs. It was shown previously that the activity of CYP2C9 in vivo is inhibited by oral contraceptives. The mechanisms of this effect have not been elucidated. We hypothesize that this may occur because of the sex steroid-dependent activation of estrogen receptor alpha (ER alpha) with further transactivation of the CYP2C9 gene. Here, we show that the CYP2C9 promoter indeed contains a functionally relevant estrogen responsive element (ERE) half-site at position -149/-145. Its ER alpha binding activity was tested by the luciferase gene reporter assay. Promoter constructs bearing this site were cotransfected with ER alpha into Huh7 hepatoma cells and treated with various ER alpha ligands including 4-hydroxytamoxifen (4-OHT), raloxifene (R), 17 beta-estradiol (EE), and 17 alpha-ethinylestradiol (ETE). The luciferase activity driven by the wild-type CYP2C9 promoter construct was up-regulated by 4-OHT and R and significantly or marginally suppressed by ETE and EE, respectively. An identical effect was observed in primary hepatocytes treated with these compounds. Mutations introduced into the ERE half-site abolished the observed effects in the Huh7 cells. Electrophoretic mobility-shift assay revealed sequence-specific binding of a nuclear protein to the oligonucleotide containing the ERE half-site, which was identified as ER alpha by antibody supershift analysis. In addition, the association of ER alpha with CYP2C9 promoter was strongly supported by chromatin immunoprecipitation data. Taken together, these results indicate that ER alpha and its ligands play an important role in the regulation of CYP2C9 expression.
dc.description.sponsorshipTorsten och Ragnar Soderbergs Stiftelser; Swedish Research Council; Lundbeck Foundation; Portuguese Foundation for Science and Technology
dc.description.versioninfo:eu-repo/semantics/publishedVersion
dc.identifier.doi10.1124/jpet.110.175075
dc.identifier.issn0022-3565
dc.identifier.urihttp://hdl.handle.net/10400.1/11471
dc.language.isoeng
dc.peerreviewedyes
dc.publisherAmerican Society for Pharmacology and Experimental Therapeutics
dc.subjectTranscription factor Gata-4
dc.subjectPregnane X receptor
dc.subjectNuclear factor-4-Alpha
dc.subjectDrug-metabolism
dc.subjectGene-expression
dc.subjectHuman liver
dc.subjectEr-Alpha
dc.subjectPolymorphisms
dc.subjectInduction
dc.subjectPromoter
dc.titleThe ligands of estrogen receptor alpha regulate Cytochrome P4502C9 (CYP2C9) expression
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage309
oaire.citation.issue1
oaire.citation.startPage302
oaire.citation.titleJournal of Pharmacology and Experimental Therapeutics
oaire.citation.volume338
person.familyNameLopes Neve Cavaco
person.givenNameIsa da Conceição
person.identifier.orcid0000-0002-8629-7129
person.identifier.scopus-author-id6602806914
rcaap.rightsrestrictedAccess
rcaap.typearticle
relation.isAuthorOfPublication621412af-f03a-4940-bd7e-2bada5f7cfc8
relation.isAuthorOfPublication.latestForDiscovery621412af-f03a-4940-bd7e-2bada5f7cfc8

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
The_Ligands_of_Estrogen_Receptor_alpha_Regulate_Cy.pdf
Size:
1.28 MB
Format:
Adobe Portable Document Format
Download

Collections

FCB2-Artigos (em revistas ou actas indexadas)